MoonLake Immunotherapeutics

MLTX · Nasdaq · SIC 2834: Pharmaceutical Preparations
89
SEC Filings

Business Summary

Overview We are a clinical stage biotechnology company advancing therapies to address significant unmet needs in inflammatory skin and joint diseases. We are currently a single asset company focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody, that we exclusively licensed from MHKDG and that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. SLK is a proprietary Nan...

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMLTXdiscussed_in_filing Cybersecurity
topic_mentionMLTXdiscussed_in_filing Trusted Computing
topic_mentionMLTXdiscussed_in_filing Blockchain & Crypto
topic_mentionMLTXdiscussed_in_filing Capital Expenditure
topic_mentionMLTXdiscussed_in_filing Supply Chain
topic_mentionMLTXdiscussed_in_filing Regulation
topic_mentionMLTXdiscussed_in_filing Healthcare & Bio
topic_mentionMLTXdiscussed_in_filing Sovereign & Government
topic_mentionMLTXdiscussed_in_filing Cybersecurity
topic_mentionMLTXdiscussed_in_filing Trusted Computing
topic_mentionMLTXdiscussed_in_filing Blockchain & Crypto
topic_mentionMLTXdiscussed_in_filing Capital Expenditure
topic_mentionMLTXdiscussed_in_filing Supply Chain
topic_mentionMLTXdiscussed_in_filing Regulation
topic_mentionMLTXdiscussed_in_filing Healthcare & Bio
topic_mentionMLTXdiscussed_in_filing Sovereign & Government
topic_mentionMLTXdiscussed_in_filing Cybersecurity
topic_mentionMLTXdiscussed_in_filing Trusted Computing
topic_mentionMLTXdiscussed_in_filing Blockchain & Crypto
topic_mentionMLTXdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001821586-26-000002EDGAR87K words
2025-02-262024-12-310001821586-25-000006EDGAR—
2024-02-292023-12-310001821586-24-000008EDGAR—
2023-03-202022-12-310001821586-23-000007EDGAR—
2022-02-172021-12-310001213900-22-008253EDGAR—
2021-03-312020-12-310001213900-21-019007EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001821586-25-000022EDGAR27K words
2025-08-052025-06-300001821586-25-000018EDGAR—
2025-05-122025-03-310001821586-25-000011EDGAR—
2024-11-072024-09-300001821586-24-000029EDGAR—
2024-08-072024-06-300001821586-24-000025EDGAR—
2024-05-072024-03-310001821586-24-000020EDGAR—
2023-11-142023-09-300001821586-23-000022EDGAR—
2023-08-102023-06-300001821586-23-000015EDGAR—
2023-05-112023-03-310001821586-23-000012EDGAR—
2022-11-142022-09-300001821586-22-000009EDGAR—
2022-08-122022-06-300001821586-22-000006EDGAR—
2022-05-162022-03-310001213900-22-027086EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-230001213900-26-018967EDGAR4K words
2026-01-080001213900-26-002344EDGAR—
2025-11-050001213900-25-106723EDGAR—
2025-11-050001821586-25-000021EDGAR—
2025-09-290001213900-25-092614EDGAR—
2025-08-050001821586-25-000016EDGAR—
2025-06-060001213900-25-052140EDGAR—
2025-05-120001821586-25-000009EDGAR—
2025-04-290001213900-25-036363EDGAR—
2025-04-030001213900-25-028366EDGAR—

89 total filings indexed. 61 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001821586
TickerMLTX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedE9

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: dc8443e698d8823650d9f68a8be1943af0e9da47d0c1ba6fe604f95acb09d33f
parent: 4b0d67e5042699ebd8a66126ad6f6920ef48eac42751d1d9fef2e8f305fe35ff
content hash: 77ebf734e6577ba8ee69b7f56a756c0321e98e62abbc84d3f6cabef690663f99
signed: 2026-04-13T04:46:17.767Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf